GB2072536A — Nebuliser
Assigned to Individual · Expires 1981-10-07 · 45y expired
What this patent protects
The apparatus is self-contained for carriage in a pocket or handbag and comprises a nebulising chamber 12 from which tangentially extends an outlet tube 14 leading to a perpendicular head 15 provided with a mouthpiece 16. The chamber is cylindrical and houses a rotatable disc 25.…
USPTO Abstract
The apparatus is self-contained for carriage in a pocket or handbag and comprises a nebulising chamber 12 from which tangentially extends an outlet tube 14 leading to a perpendicular head 15 provided with a mouthpiece 16. The chamber is cylindrical and houses a rotatable disc 25. An adjustable air inlet 30 is provided in the chamber and material to be nebulised is introduced to the chamber 12 through the mouth 14c. The disc 25 is driven by a battery and electric motor in the casing 29 and both draws air in through the inlet 30 and breaks up the material in the casing to nebulise it. Baffles 40, 41 control the size of particles expelled and a damping connection 44 reducing unpleasantness to the user from vibrations. <IMAGE>
Drugs covered by this patent
- Remodulin (TREPROSTINIL) · United Therap
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.